Murray, UTNCT06232551Now EnrollingIRB Ready

Venous Thromboembolic Disease Clinical Trial in Murray, UT

Access cutting-edge venous thromboembolic disease treatment through this clinical trial at a research site in Murray. Study-provided care at no cost to qualified participants.

Sponsored by Scott C. Woller, MD

Quick Self-Assessment

See if you qualify for this Murray location

Preparing your pre-screening questions…

Expert Care in Murray

Access venous thromboembolic disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related venous thromboembolic disease treatment provided free

Apply for This Murray Location

Check if you qualify for this venous thromboembolic disease clinical trial in Murray, UT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Murray

    Convenient for UT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Murray site if eligible
  4. 4Begin participation

About This Venous Thromboembolic Disease Study in Murray

A new algorithm derived from only patient age and components of the complete blood count and basic metabolic panel can identify patients discharged from the hospital who may benefit from a blood thinner (called rivaroxaban) to decrease their risk of blood clots, and for whom the risk of bleeding is minimal. The purpose of this study is to evaluate the use of a pop-up alert, which will be seen by clinicians when a discharging patient has been identified as being someone for whom the risk of blood clots is high, but for whom bleeding risk is estimated to be low. The pop-up alert will be enabled in a sequential fashion for each group of hospitals in 1 month blocks. We will look to see if the pop-up alert changes the number of patients who receive rivaroxaban. We will also measure the outcomes of blood clots and bleeding among all discharging patients.

Sponsor: Scott C. Woller, MD

Who Can Participate

Inclusion Criteria

Discharging clinician must be in one of the following iCentra electronic health record (Cerner, Kansas City, MO) positions:
Physician, nurse practitioner, or physician assistant hospitalist
Physician internal medicine
Physician family medicine
Patient age ≥ 18 years.
The encounter must be inpatient.
A signed hospital discharge order must be present.
eVTE target population criteria (increased venous thromboembolism risk, low bleeding risk) must be met

Exclusion Criteria

Pregnant during encounter
Discharge order completed by ineligible clinician type
Exclude all cases where the patient is being actively prescribed and intended to be discharged on the following qualifying anticoagulant medications, regardless of dose form or dosing regimen (i.e., they have an active prescription for one of these medications):
Fondaparinux
Rivaroxaban
Creatinine clearance \<30 milliliters/minute based on last-available eligible serum creatinine value preceding discharge
Estimated creatine clearance based on actual body weight (preferred) ((140 - age years) \
measured weight kilograms) / (72.0 \
serum creatine milligrams/deciliter) (\*0.85 if female)) = milliliters/minute
If measured body weight not available, then based on ideal body weight ((140 - age years) \
ideal body weight kilograms) / (72.0 \
serum creatine milligrams/deciliter) (\*0.85 if female)) = milliliters/minute

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Murray?

Yes, this clinical trial (NCT06232551) has an active research site in Murray, UT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Venous Thromboembolic Disease Treatment Options in Murray, UT

If you're searching for venous thromboembolic disease treatment options in Murray, UT, this clinical trial (NCT06232551) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Murray research site is actively enrolling participants for this clinical trial. You'll receive care from experienced venous thromboembolic disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all venous thromboembolic disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Murray, UT

See all ankylosing spondylitis clinical trials recruiting in Murray — not just this study.

Browse Ankylosing Spondylitis Trials in Murray →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Murray?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Murray, UT